Merriam-Webster has updated its entry on “Chinese restaurant syndrome,” a term many Asian Americans saw as antiquated and even racist.
The phrase was previously defined as a legitimate illness brought on by food seasoned with monosodium glutamate but “especially Chinese food.” Merriam-Webster.com said symptoms include numbness of the neck, arms and back as well as headaches and dizziness.
Now, the definition has a detailed disclaimer noting the term as “dated” and “offensive.” It also states research conducted since the so-called syndrome was reported in the 1960s has not found any link between MSG and those symptoms.
It also contains a link to another entry — the more clinical term, “MSG symptom complex.”
Peter Sokolowski, editor at large at Merriam-Webster, confirmed the changes.
“This process is always ongoing, and includes the gathering of evidence and drafting of revisions to be reviewed by specialized and senior editors before being added to a scheduled release of changes,” he said.
He did not say when the revisions were made.
The issue gained attention in January when Ajinomoto, a longtime Japanese producer of MSG seasonings, called on Merriam-Webster to alter its entry. The company hired restaurateur Eddie Huang and “The Real” TV co-host Jeannie Mai for a social media campaign.
MSG comes from glutamate, a common amino acid or protein building block found in food. The Food and Drug Administration says MSG is generally recognized as a safe addition to food. In previous studies with people identifying as sensitive to MSG, researchers found that neither MSG nor a placebo caused consistent reactions, the agency said.
8 Pharmaceutical Companies Working on a Coronavirus Cure
We are living through interesting times. Not an hour goes by when Americans don’t receive some reminder of the impact the coronavirus has on our lives. The race is on for an effective, FDA-approved treatment for the virus. Despite, vaccines being available for human trial in record time, we are many months away from having a viable vaccine.
However, we may be somewhat closer in finding some antiviral treatments. And if you’ve watched the market closely this week, any news on that front tends to move the market in a positive direction.
That brings up another truth of investing. There are some stocks that thrive from other stocks misery. And that’s why we’ve put together this special report. If you’re an investor who is looking to jump into this bear market, the pharmaceutical sector is a logical choice.
A combination of big-name drug companies as well as smaller startup companies are working around the clock to develop vaccines or treatments that will target the infection caused by the novel coronavirus.
View the “8 Pharmaceutical Companies Working on a Coronavirus Cure”.
All copyrights for this article are reserved to Marketbeat